Lorenzo Foffano

Aviano, 33081, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Time-varying hazard rates reveal patterns of progression in HR+/HER2- metastatic breast cancer: Towards risk-adapted monitoring.

Time-varying hazard rates reveal patterns of progression in HR+/HER2- metastatic breast cancer: Towards risk-adapted monitoring.

Journal: Translational oncology
Published: July 06, 2026

Associations of neighborhood deprivation with breast cancer tumor genomics, targeted treatment use, and survival.

Associations of neighborhood deprivation with breast cancer tumor genomics, targeted treatment use, and survival.

Journal: Breast cancer research and treatment
Published: February 15, 2026

Combining circulating tumor cells and tumor-derived extracellular vesicles for prognosis stratification in patients with metastatic breast cancer.

Combining circulating tumor cells and tumor-derived extracellular vesicles for prognosis stratification in patients with metastatic breast cancer.

Journal: ESMO open
Published: October 28, 2025

Epigenetic and fragment-based profiling across CDK4/6 inhibitors in first-line HR+/HER2- metastatic breast cancer. An ancillary analysis of the MAGNETIC.1 study.

Epigenetic and fragment-based profiling across CDK4/6 inhibitors in first-line HR+/HER2- metastatic breast cancer. An ancillary analysis of the MAGNETIC.1 study.

Journal: Breast (Edinburgh, Scotland)
Published: June 24, 2025

Racial Differences in ctDNA Profiles, Targeted Therapy Use, and Outcomes in Metastatic Breast Cancer.

Racial Differences in ctDNA Profiles, Targeted Therapy Use, and Outcomes in Metastatic Breast Cancer.

Journal: JAMA network open
Published: February 26, 2025

Immunotherapy in Oncogene-Addicted NSCLC: Evidence and Therapeutic Approaches.

Immunotherapy in Oncogene-Addicted NSCLC: Evidence and Therapeutic Approaches.

Journal: International journal of molecular sciences
Published: December 20, 2024

Hallmarks of Appetite: A Comprehensive Review of Hunger, Appetite, Satiation, and Satiety.

Hallmarks of Appetite: A Comprehensive Review of Hunger, Appetite, Satiation, and Satiety.

Journal: Current obesity reports
Published: December 18, 2024

Longitudinal profiling of hormone receptor positive, HER2 negative metastatic breast cancer through droplet digital PCR-based circulating tumor DNA fragmentomics.

Longitudinal profiling of hormone receptor positive, HER2 negative metastatic breast cancer through droplet digital PCR-based circulating tumor DNA fragmentomics.

Journal: Translational oncology
Published: December 15, 2024

Cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i): Mechanisms of resistance and where to find them.

Cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i): Mechanisms of resistance and where to find them.

Journal: Breast (Edinburgh, Scotland)
Published: October 12, 2024

Beyond Hormone Receptors: liquid biopsy tools to unveil new clinical meanings and empower therapeutic decision-making in Luminal-like metastatic breast cancer.

Beyond Hormone Receptors: liquid biopsy tools to unveil new clinical meanings and empower therapeutic decision-making in Luminal-like metastatic breast cancer.

Journal: Breast (Edinburgh, Scotland)
Published: September 07, 2024

Is ctDNA ready to outpace imaging in monitoring early and advanced breast cancer?

Is ctDNA ready to outpace imaging in monitoring early and advanced breast cancer?

Journal: Expert review of anticancer therapy
Published: June 10, 2024

Integrating machine learning-predicted circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in metastatic breast cancer: A proof of principle study on endocrine resistance profiling.

Integrating machine learning-predicted circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in metastatic breast cancer: A proof of principle study on endocrine resistance profiling.

Journal: Cancer letters
Published: April 10, 2024
Showing 1-12 of 14

Last Updated: 09/26/2026